US FDA approves Lilly’s Mounjaro to reduce cardiovascular risk
The US FDA approved Lilly’s Mounjaro to reduce cardiovascular risk.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The US FDA approved Lilly’s Mounjaro to reduce cardiovascular risk.